M3 muscarinic receptor antagonists (Friedrich-Alexander-Universitaet Erlangen-Nuernberg)

N/A

Report date: 2025/01/26 18:50:33
NME

Base Information

Drug NameM3 muscarinic receptor antagonists (Friedrich-Alexander-Universitaet Erlangen-Nuernberg)
Drug Alias NameOFH-243
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsUrinary Bladder, OveractivePulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFriedrich-Alexander-Universitaet Erlangen-Nuernberg
China Registration ClassN/A

Develop Information

Active CompaniesFriedrich-Alexander-Universitaet Erlangen-Nuernberg
Inactive CompaniesN/A
Active IndicationsUrinary Bladder, OveractivePulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A